Changeflow GovPing Pharma & Healthcare VR Upper Limb Rehabilitation for Chronic Stroke...
Routine Notice Added Final

VR Upper Limb Rehabilitation for Chronic Stroke Randomized Trial

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH/NLM registered a randomized controlled trial (NCT07534124) evaluating non-immersive virtual reality rehabilitation (MindMotion GO) versus conventional occupational therapy for upper limb motor function in chronic stroke patients. The 8-week study with 3-month follow-up will assess motor function, daily living performance, quality of life, and neuroplastic changes via EEG. Enrollment and results will be posted to ClinicalTrials.gov.

What changed

NIH/NLM registered a new randomized controlled trial on ClinicalTrials.gov. The study will compare non-immersive virtual reality-based rehabilitation using the MindMotion GO system against conventional occupational therapy in 60+ chronic stroke patients. Both groups receive twice-weekly 40-minute sessions for eight weeks, with outcomes assessed at baseline and 3-month follow-up.

Compliance and regulatory affairs professionals tracking clinical research should note this trial registration for pipeline monitoring purposes. Healthcare providers and clinical investigators involved in stroke rehabilitation research may find this protocol relevant for competitive intelligence or potential collaboration. The study does not create immediate compliance obligations but adds to the evidence base on digital health interventions in neurorehabilitation.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Virtual Reality-Based Upper Limb Rehabilitation in Chronic Stroke: A Randomized Trial

N/A NCT07534124 Kind: NA Apr 16, 2026

Abstract

This randomized controlled study aims to evaluate the effectiveness of non-immersive virtual reality-based rehabilitation using the MindMotion™ GO system compared with conventional occupational therapy for improving upper limb motor function in individuals with chronic stroke. Stroke is a leading cause of long-term disability in adults worldwide, and barriers such as limited access to rehabilitation services, low motivation, and reduced adherence may hinder recovery in the chronic phase.

Participants will be randomly assigned to either an experimental group receiving non-immersive virtual reality training or a control group receiving conventional occupational therapy according to standard clinical practice. Both groups will complete two rehabilitation sessions per week for eight weeks, with each session lasting approximately 40 minutes.

The study will assess upper limb motor function, performance in activities of daily living, and quality of life. In addition, electroencephalography (EEG) will be used before and after the intervention to explore potential neuroplastic changes associated with rehabilitation.

Outcome assessments will be conducted at baseline and at follow-up approximately three months after the initial evaluation. The results of this study may help determine whether non-immersive virtual reality is an effective and accessible tool to enhance rehabilitation outcomes in individuals with chronic stroke.

Conditions: Stroke, Rehabilitation, Upper Limb Paresis, Chronic Stroke Patient

Interventions: Non-Immersive Virtual Reality Rehabilitation, Occupational Therapy

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH/NLM
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07534124

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Medical rehabilitation research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!